Hepcvel Tablets – Sofosbuvir + Velpatasvir Pan-Genotypic Hepatitis C Treatment

Hepcvel (Sofosbuvir / Velpatasvir) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Hepcvel deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Sofosbuvir (400mg) + Velpatasvir (100mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Natco Pharma Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.